Matches 301 - 350 out of 449 < 1 2 3 4 5 6 7 8 9 >
Match Document Document Title
5110605 Calcium polycarbophil-alginate controlled release composition and method  
A polymeric complex composition comprising a reaction complex formed by the interaction of a polycarbophil component with alginic acid or a salt thereof, said interaction being performed in the...
5102666 Calcium polycarbophil controlled release composition and method  
Controlled release compositions comprising calcium polycarbophil and an active agent selected from the group consisting of medicinal agents, breath fresheners, and flavors, and a method of...
5096717 Double-coated granules of disodium pamidronate  
The invention relates to an advantageous oral administration from the disodium pamidronate in capsules. These capsules are filled with double-coated granules. The inner coating is hydrophilic and...
5091175 Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane  
A pharmaceutical composition useful for treating hypercholesterolemia comprising a bile acid sequestrant resin such as cholestyramine and cholestipol maintained in a semipermeable water-insoluble...
5087455 Hollow granular medicine and its preparation  
A granular medicine with slow drug-release characteristics that is sufficiently absorbed in the intestines, in which the granular medicine has a hollow spherical structure, a drug is dispersed in...
5087454 Ibuprofen tablet  
Ibuprofen tablets/caplets formed by wet granulation of the ibuprofen characterized by a dissolution profile maintained stable on aging by incorporating croscarmellose sodium separately into the wet...
5085865 Sustained release pharmaceutical preparations containing an analgesic and a decongestant  
An orally administrable sustained-release pharmaceutical tablet having at least two layers, which are directly compressible, is disclosed. The first layer, an immediate-release layer, contains an...
5082669 Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked  
A rapid-releasing oral particle pharmaceutical preparation with its unpleasant taste masked comprising a core and a film layer coating the core, the core at least containing a drug having an...
5075114 Taste masking and sustained release coatings for pharmaceuticals  
Chewable medicament tablets are made from coated granules of a medicament wherein the coating on said granules comprises a blend of cellulose actate and/or cellulose acetate butyrate and...
5073380 Oral sustained release pharmaceutical formulation and process  
A pharmaceutical sustained release tablet or tablet layer is formed by making a wet granulation, using povidone (PVP) in water or alcohol-water as the granulating fluid which is mixed with a...
5073384 Maltodextrin/defoaming composition combinate  
A consumable antigas or antiflatulent composition is produced by combining a water soluble agglomerated maltodextrin and a fluid, nonaqueous, defoaming or antifoaming composition such as...
5069910 Dispersible cimetidine tablets  
There are described novel dispersible cimetidine tablets containing 30 to 90% by weight of one of the polymorphous modifications of cimetidine A, B or C, 5 to 55% by weight of one or more...
5069911 Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions  
A controlled release formulation for oral administration comprising a 9,10-dihydro ergot alkaloid, a pharmaceutically acceptable hydrophilic swelling substance and a pharmaceutically...
5059595 Pharmaceutical compositions containing 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in controlled-release form active in the therapy of organic mental disturbances  
This invention relates to pharmaceutical compositions containing 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutical acceptable salts in controlled-release form...
5047246 Direct compression cyclophosphamide tablet  
A directly compressible pharmaceutical composition comprising cyclophosphamide and a partially or fully pregelatinized starch is disclosed. The pharmaceutical composition, when directly compressed...
5037658 Direct dry compressible acetaminophen composition  
This invention relates to analgesic composition and more particularly, to a directly dry compressible composition comprising at least about 70% by dry weight of the composition of acetaminophen and...
5030447 Pharmaceutical compositions having good stability  
A pharmaceutical compositions is provided which has excellent stability, when dispersed in water has a pH of at least about 9, and includes a medicament which is sensitive to a low pH environment...
5030455 Sustained-release drug preparation  
A sustained-release drug preparation comprises a water-soluble drug, a lipidic substance and an oil as its essential components. The drug level in the blood is sustained at a preferable...
5028433 Readily absorbable drug formulation of NB-818  
A readily absorbable drug formulation obtained by incorporating to a water-soluble or enteric polymer, both a nonionic surfactant and (±)-2-carbamoyloxymethyl-4-...
5024842 Annealed coats  
A dosage form is disclosed comprising a coat that surrounds a drug. The coat comprises a subcoat and an overcoat thermally annealed to provide a single unit coat around the drug.
5019396 Delivery dispenser for treating cardiac arrhythmias  
A dosage form is disclosed comprising a first composition comprising two different polyethylene oxide osmopolymers for delivering a drug at a controlled rate over time.
5015480 Film coating formulations  
Aqueous diffusion coating formulations suitable for use on pharmaceutical dosage forms comprising an admixture of an insoluble polymer component of a copolymer of ethylacrylate and...
5013728 Composition for treating osteoporosis and hormonal imbalance  
A medication for providing fluoride ion for the prevention and treatment of bone loss disease, together with an estrogen-containing substance for not only treating hormonal imbalance but to obtain...
5009897 Pharmaceutical granules and tablets made therefrom  
A pharmaceutical granule comprising a core of active pharmaceutical agent and a coating of a polymer/microcrystalline cellulose is provided. These granules permit superior tableting of...
5009887 Deodorant composition in the form of a gel  
A new deodorant composition in the form of gel is now provided, which comprises 2% to 30% by weight of sodium polyacrylate or ammonium polyacrylate having a molecular weight of form 40,000 to...
5004613 Oral sustained release pharmaceutical formulation and process  
A pharmaceutical sustained release tablet or tablet layer is formed by making a wet granulation, using povidone (PVP) in water or alcohol-water as the granulating fluid which is mixed with a...
5002774 Sustained release pharmaceutical tablet  
A sustained release solid composition for delivering an amount of a pharmaceutical material, prticularly magnesium lactate, to the gastro-intestinal tract comprising: an active pharmaceutical...
4996220 Method of producing a clathrate compound  
A clathrate compound is produced if a powdery host compound which reacts with a microbicide to form the clathrate compound is added into an aqueous solution of the microbicide. If the microbicide...
4990335 Use of vinyl alcohol homopolymer and copolymers for tableting active materials  
Method of making tablets for active ingredient delivery by compressing a mixture of active ingredient and granular, high viscosity, fully hydrolyzed polyvinyl alcohol or copolymer of vinyl alcohol...
4983400 Controlled release combination of carbidopa/levodopa  
A matrix or monolithic drug delivery system for the controlled release of carbidopa and levodopa consists of the two drugs uniformly dispersed in a polymer vehicle at a concentration that is...
4975283 Stabilized enteric coated aspirin granules and process for preparation  
A stabilized enteric coated aspirin granule product prepared by commingling the enteric coated aspirin granules with glutamic acid hydrochloride.
4970078 Crosslinked carboxymethyguar tablet disintegrant  
Tablets containing 1-2% by weight carboxymethylguar as a disintegrant are equivalent to tablets containing sodium carboxymethylcellulose in medicant release. These tablets can be made at a lower...
4970075 Controlled release bases for pharmaceuticals  
The release of therapeutically active agents from controlled release bases is extended by using a combination of a higher aliphatic alcohol and an acrylic resin as the base material.
4968509 Oral sustained release acetaminophen formulation and process  
An acetaminophen-sustained release tablet or tablet layer is formed by making a wet granulation, using Povidone (PVP) in water or alcohol-water as the granulating fluid which is mixed with...
4968508 Sustained release matrix  
This invention provides a matrix composition for sustained drug delivery which is comprised of an active agent, a hydrophilic polymer and an enteric polymer. The enteric polymer is impermeable to...
4966770 Prednisone microencapsulated granules  
The invention disclosed is prednisone microencapsulated granules with activity densities greater than about 0.030 g/ml. These granules are unusually small, having diameters less than about 1000...
4966768 Sustained release etodolac  
A sustained release dosage form of etodolac is provided which is a tablet having as essential components etodolac, hydroxyproplymethylcellulose, ethylcellulose and a release rate modifying agent...
4966772 DHP delayed release preparation  
A solid medicament preparation having long-lasting action containing a sparingly soluble dihydropyridine active compound of the Formula (I) ##STR1## the preparation having a core-coating...
4954349 Oral magnesium and potassium compositions and use  
Solid oral composition for the treatment or prophylaxis of potassium and magnesium deficiency in skeletal and cardiac muscle containing about 3 to about 50 milliequivalent bioavailable potassium,...
4942040 Pharmaceutical preparation and a process for its preparation  
Preparation giving a controlled and extended release of both a dihydropyridine, e.g. felodipine and a β-adrenoreceptor antagonist, namely metoprolol as well as a method for the manufacture of the...
4937080 Granular product (I)  
The present invention relates to a granular product comprised of a solid product which has been provided with a coating of a melt of itself, as well as a process for the preparation of the granular...
4927639 Modified release gemfibrozil composition  
A disintegratable formulation of gemfibrozil providing both immediate and sustained release and comprises a tablet compressed from a mixture of a first and second granulation, and a disintegration...
4925674 Amoxicillin microencapsulated granules  
The invention disclosed is amoxicillin microencapsulated granules with activity densities greater than about 0.200 g/ml. These granules are unusually small having diameters less than about 1000...
4925676 Extended release gemfibrozil composition  
A disintegratable gemfibrozil tablet providing both immediate and enteric release is compressed from a mixture of a first granulation of gemfibrozil with at least one acid-disintegratable binder...
4925672 Products containing a calcium antagonist and a lipid-lowering agent  
Combinations of calcium antagonists and lipid-lowering agents are suitable for controlling diseases.
4925675 Erythromycin microencapsulated granules  
The invention disclosed is erythromycin microencapsulated granules activity densities greater than about 0.300 g/ml. These granules are unusually small having diameters less than about 1000...
4917899 Controlled absorption diltiazem formulation  
A diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid and a lubricant, and a...
4910023 Drug in combination with flavor masking agent and method for making same  
According to this invention various hygroscopic malflavored drugs can be proceeded by a unique wet granulation process wherein a slurry of the drug in water is dried in combination with colloidal...
4904478 Slow-release sodium fluoride tablet and method for treatment of osteoporosis  
A novel slow-release sodium fluoride preparation and its use. Such slow-release sodium preparation comprises carnauba wax and talc and may be used to provide a safe but effective level of fluoride...
4902516 Binder-free granules with delayed release of the active compound  
Binder-free granules for oral and parenteral administration with delayed release of the active compound, consisting of a pharmaceutical active compound or granules thereof and a coating of 1 to 20%...
Matches 301 - 350 out of 449 < 1 2 3 4 5 6 7 8 9 >